Check out the study “Challenges in the Development of Intravenous Neurokinin-1 Receptor Antagonists: Results of a Safety and Pharmacokinetics Dose-Finding, Phase 1 Study of Intravenous Fosnetupitant”

Challenges in the Development of Intravenous Neurokinin-1 Receptor Antagonists Results of a Safety and Pharmacokinetics Dose-Finding, Phase 1 Study of Intravenous Fosnetupitant
Share

Have you already read this interesting publication on PubMed? 📑 📢

Check out the study “Challenges in the Development of Intravenous Neurokinin-1 Receptor Antagonists: Results of a Safety and Pharmacokinetics Dose-Finding, Phase 1 Study of Intravenous Fosnetupitant” to delve into the key findings and implications.

We congratulate the team for their hard work and dedication! Read the publication here: https://pubmed.ncbi.nlm.nih.gov/36263927/